TREACE MEDICAL CONCEPTS INC. - COMMON STOCK

Treace to Report Second Quarter 2025 Financial Results on August 7, 2025

24 июл 2025 13:05:00 Источник Nasdaq GlobeNewswire

Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology

05 июн 2025 10:00:00 Источник Nasdaq GlobeNewswire

Treace Medical Concepts Reports First Quarter 2025 Financial Results

08 май 2025 13:05:01 Источник Nasdaq GlobeNewswire

Treace to Report First Quarter 2025 Financial Results on May 8, 2025

24 апр 2025 13:05:00 Источник Nasdaq GlobeNewswire

Treace Announces Upcoming Board Chair Transition

07 апр 2025 05:00:00 Источник Nasdaq GlobeNewswire

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference

28 мар 2025 11:00:00 Источник Nasdaq GlobeNewswire

Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference

25 мар 2025 13:15:00 Источник Nasdaq GlobeNewswire

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial Results

27 фев 2025 13:05:01 Источник Nasdaq GlobeNewswire

Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

06 фев 2025 13:15:00 Источник Nasdaq GlobeNewswire

Treace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression Implant

30 янв 2025 05:00:00 Источник Nasdaq GlobeNewswire

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue

13 янв 2025 05:00:01 Источник Nasdaq GlobeNewswire

Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference

02 янв 2025 13:15:00 Источник Nasdaq GlobeNewswire

Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure

30 дек 2024 05:15:00 Источник Nasdaq GlobeNewswire

Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant

16 дек 2024 05:30:00 Источник Nasdaq GlobeNewswire

Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities

04 дек 2024 13:15:00 Источник Nasdaq GlobeNewswire

Treace Appoints Guy Guglielmino as Chief Commercial Officer

02 дек 2024 13:15:00 Источник Nasdaq GlobeNewswire

Treace Announces Participation at Stifel 2024 Healthcare Conference

18 ноя 2024 13:46:28 Источник Nasdaq GlobeNewswire

Treace Medical Concepts Reports Third Quarter 2024 Financial Results

05 ноя 2024 13:05:00 Источник Nasdaq GlobeNewswire

Treace Announces Participation in the UBS Global Healthcare Conference

04 ноя 2024 14:29:50 Источник Nasdaq GlobeNewswire

Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings

04 ноя 2024 05:00:00 Источник Nasdaq GlobeNewswire